BioSpace News Archive

Insmed Incorporated today announced that management will present at the following investor conferences.

VYNE Therapeutics Inc. today announced financial results for the fourth quarter and year ended December 31, 2023 and provided a business update.

BlossomHill Therapeutics, Inc. today announced the closing of a $100 million Series B financing round.

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced the initiation of the PTAB1 Post-Market Study.

Coya Therapeutics, Inc. announces that Dr. Alireza Faridar, the Stanley H. Appel Chair in Translational Neuroscience, Stanley H. Appel Department of Neurology at Houston Methodist, will present data showing the contribution of chronic systemic inflammation and dysfunctional Tregs in Frontotemporal Dementia (FTD) patients at the AD/PD 2024 Conference.

IMUNON, Inc. announces positive results from a live virus challenge study conducted for IMUNON by the Wistar Institute with IMNN-101 against the SARS-CoV-2 variant XBB.1.5.

Autonomix Medical, Inc. announced it has entered into a clinical site agreement with “АКFА MEDLINE” Ltd., for its PoC human clinical trial evaluating the use of transvascular RF ablation for the treatment of pancreatic cancer pain.

SciSparc Ltd. today announced that it has successfully completed the manufacturing of and delivered its innovative SCI- 210 treatment, in accordance with its initiation of enrollment for the clinical trial at the Soroka Medical Center of pediatric patients who have Autism Spectrum Disorder (“ASD”).

SpringWorks Therapeutics, Inc. announced today that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for nirogacestat, an oral gamma secretase inhibitor, for the treatment of adults with desmoid tumors.

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) today announced that David O’Toole, Chief Financial Officer, will present at TD Cowen’s 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:50 a.m. Eastern Time.